DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,879 | +4.0% | 1,511 | +0.6% | 0.07% | +7.4% |
| Q2 2023 | $360,480 | -37.9% | 1,502 | -34.8% | 0.07% | -41.9% |
| Q1 2023 | $580,196 | +6.4% | 2,302 | +12.1% | 0.12% | -0.8% |
| Q4 2022 | $545,173 | -37.2% | 2,054 | -38.9% | 0.12% | -46.8% |
| Q3 2022 | $868,000 | -1.4% | 3,361 | -3.2% | 0.22% | -1.8% |
| Q2 2022 | $880,000 | -11.8% | 3,471 | +2.0% | 0.23% | -2.2% |
| Q1 2022 | $998,000 | -20.0% | 3,403 | -10.2% | 0.23% | -19.2% |
| Q4 2021 | $1,247,000 | +14.3% | 3,790 | +5.7% | 0.29% | -1.7% |
| Q3 2021 | $1,091,000 | +17.9% | 3,584 | +4.0% | 0.29% | +16.9% |
| Q2 2021 | $925,000 | +90.7% | 3,446 | +59.9% | 0.25% | +70.5% |
| Q1 2021 | $485,000 | +18.0% | 2,155 | +16.5% | 0.15% | +9.0% |
| Q4 2020 | $411,000 | +37.0% | 1,850 | +41.4% | 0.13% | +18.6% |
| Q3 2020 | $300,000 | +35.1% | 1,308 | +4.0% | 0.11% | +25.6% |
| Q2 2020 | $222,000 | +8.8% | 1,258 | +4.7% | 0.09% | 0.0% |
| Q1 2020 | $204,000 | – | 1,201 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |